U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
Allogeneic T lymphocytes obtained from peripheral blood mononuclear cells by leukapheresis of healthy volunteer donors, transduced with a self-inactivating, non-replicating lentiviral vector encoding a chimeric antigen receptor (CAR) targeting human CD19
Preferred Name English
Cemacabtagene Ansegedleucel
INN  
Official Name English
cemacabtagene ansegedleucel [INN]
Common Name English
Code System Code Type Description
FDA UNII
W3X22HS7XD
Created by admin on Wed Apr 02 17:09:42 GMT 2025 , Edited by admin on Wed Apr 02 17:09:42 GMT 2025
PRIMARY
NCI_THESAURUS
C172708
Created by admin on Wed Apr 02 17:09:42 GMT 2025 , Edited by admin on Wed Apr 02 17:09:42 GMT 2025
PRIMARY
INN
12556
Created by admin on Wed Apr 02 17:09:42 GMT 2025 , Edited by admin on Wed Apr 02 17:09:42 GMT 2025
PRIMARY
SMS_ID
300000026952
Created by admin on Wed Apr 02 17:09:42 GMT 2025 , Edited by admin on Wed Apr 02 17:09:42 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966